ATM-deficient thymic lymphoma is associated with aberrant tcrd rearrangement and gene amplification

Journal of Experimental Medicine

Volumn 207, Issue 7, 2010, Pages 1369-1380

  Zha, Shan ^a   Bassing, Craig H ^a,d   Sanda, Takaomi ^b   Brush, James W ^a   Patel, Harin ^a   Goff, Peter H ^a   Murphy, Michael M ^a   Tepsuporn, Suprawee ^a   Gatti, Richard A ^c   Look, A Thomas ^b   Alt, Frederick W ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR DELTA CHAIN;

ANIMAL EXPERIMENT; ARTICLE; CARCINOGENESIS; CHROMOSOME 12; CHROMOSOME ABERRATION; CHROMOSOME TRANSLOCATION; DNA STRAND BREAKAGE; GENE AMPLIFICATION; GENE DELETION; GENE EXPRESSION REGULATION; GENE LOCUS; GENE REARRANGEMENT; GENETIC RECOMBINATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TELOMERE; THYMOCYTE; THYMUS LYMPHOMA;

ANIMALS; BASE SEQUENCE; CELL CYCLE PROTEINS; CHROMOSOMES, MAMMALIAN; CLONE CELLS; CYTOGENETIC ANALYSIS; DNA-BINDING PROTEINS; ENHANCER ELEMENTS, GENETIC; GENE AMPLIFICATION; GENE REARRANGEMENT, DELTA-CHAIN T-CELL ANTIGEN RECEPTOR; GENETIC LOCI; LYMPHOMA; MICE; MOLECULAR SEQUENCE DATA; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; THYMUS NEOPLASMS; TRANSLOCATION, GENETIC; TUMOR SUPPRESSOR PROTEINS;

EID: 77954410160     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20100285     Document Type: Article

References (46)

1. Aifantis, I., E. Raetz, and S. Buonamici. 2008. Molecular pathogenesis of T-cell leukaemia and lymphoma. Nat. Rev. Immunol. 8:380-390. doi:10.1038/nri2304 (Pubitemid 351595220)
2. Armstrong, S.A., and A.T. Look. 2005. Molecular genetics of acute lymphoblastic leukemia. J. Clin. Oncol. 23:6306-6315. doi:10.1200/JCO.2005.05. 047
3. Barlow, C., S. Hirotsune, R. Paylor, M. Liyanage, M. Eckhaus, F. Collins, Y. Shiloh, J.N. Crawley, T. Ried, D. Tagle, and A. Wynshaw-Boris. 1996. Atm-deficient mice: a paradigm of ataxia telangiectasia. Cell. 86:159-171. doi:10.1016/S00928674(00)80086-0
4. Bassing, C.H., W. Swat, and F.W. Alt. 2002. The mechanism and regulation of chromosomal V(D)J recombination. Cell. 109(Suppl):S45-S55. doi:10.1016/S00928674(02)00675-X
5. Bassing, C.H., H. Suh, D.O. Ferguson, K.F. Chua, J. Manis, M. Eckersdorff, M. Gleason, R. Bronson, C. Lee, and F.W. Alt. 2003. Histone H2AX: a dosage-dependent suppressor of oncogenic translocations and tumors. Cell. 114:359-370. doi:10.1016/S00928674(03)00566-X
6. Bassing, C.H., S. Ranganath, M. Murphy, V. Savic, M. Gleason, and F.W. Alt. 2008. Aberrant V(D)J recombination is not required for rapid development of H2ax/p53-deficient thymic lymphomas with clonal translocations. Blood. 111:2163-2169. doi:10.1182/blood-2007-08-104760
7. Bhandoola, A., H. von Boehmer, H.T. Petrie, and J.C. Zúñiga- Pflücker. 2007. Commitment and developmental potential of extrathymic and intrathymic T cell precursors: plenty to choose from. Immunity. 26:678-689. doi:10.1016/j.immuni.2007.05.009
8. Borghesani, P.R., F.W. Alt, A. Bottaro, L. Davidson, S. Aksoy, G.A. Rathbun, T.M. Roberts, W. Swat, R.A. Segal, and Y. Gu. 2000. Abnormal development of Purkinje cells and lymphocytes in Atm mutant mice. Proc. Natl. Acad. Sci. USA. 97:3336-3341. doi:10.1073/pnas.050584897
9. Bredemeyer, A.L., G.G. Sharma, C.Y. Huang, B.A. Helmink, L.M. Walker, K.C. Khor, B. Nuskey, K.E. Sullivan, T.K. Pandita, C.H. Bassing, and B.P. Sleckman. 2006. ATM stabilizes DNA double-strand-break complexes during V(D)J recombination. Nature. 442:466-470. doi:10.1038/nature04866
10. Callén, E., M. Jankovic, S. Difilippantonio, J.A. Daniel, H.T. Chen, A. Celeste, M. Pellegrini, K. McBride, D. Wangsa, A.L. Bredemeyer, et al. 2007. ATM prevents the persistence and propagation of chromosome breaks in lymphocytes. Cell. 130:63-75. doi:10.1016/j.cell.2007.06.016
11. Callén, E., S. Bunting, C.Y. Huang, M.J. Difilippantonio, N. Wong, B. Khor, G. Mahowald, M.J. Kruhlak, T. Ried, B.P. Sleckman, and A. Nussenzweig. 2009. Chimeric IgH-TCRalpha/delta translocations in T lymphocytes mediated by RAG. Cell Cycle. 8:2408-2412.
12. Chun, H.H., S. Castellví-Bel, Z. Wang, R.A. Nagourney, S. Plaeger, S.G. Becker-Catania, F. Naeim, R.S. Sparkes, and R.A. Gatti. 2002. TCL-1, MTCP-1 and TML-1 gene expression profile in non-leukemic clonal proliferations associated with ataxiatelangiectasia. Int. J. Cancer. 97:726-731. doi:10.1002/ijc.10102
13. Elson, A., Y. Wang, C.J. Daugherty, C.C. Morton, F. Zhou, J. Campos-Torres, and P. Leder. 1996. Pleiotropic defects in ataxi-atelangiectasia protein-deficient mice. Proc. Natl. Acad. Sci. USA. 93:13084-13089. doi:10.1073/pnas.93.23.13084
14. Ferrando, A.A., and A.T. Look. 2000. Clinical implications of recurring chromosomal and associated molecular abnormalities in acute lymphoblastic leukemia. Semin. Hematol. 37:381-395. doi:10.1016/S0037-1963(00)90018-0
15. Franco, S., M. Gostissa, S. Zha, D.B. Lombard, M.M. Murphy, A.A. Zarrin, C. Yan, S. Tepsuporn, J.C. Morales, M.M. Adams, et al. 2006. H2AX prevents DNA breaks from progressing to chromosome breaks and translocations. Mol. Cell. 21:201-214. doi:10.1016/j.molcel.2006.01.005 (Pubitemid 43099936)
16. Garbe, A.I., and H. von Boehmer. 2007. TCR and Notch synergize in alphabeta versus gammadelta lineage choice. Trends Immunol. 28:124-131. doi:10.1016/j.it.2007.01.004
17. Giblin, W., M. Chatterji, G. Westfield, T. Masud, B. Theisen, H.L. Cheng, J. DeVido, F.W. Alt, D.O. Ferguson, D.G. Schatz, and J. Sekiguchi. 2009. Leaky severe combined immunodeficiency and aberrant DNA rearrangements due to a hypomorphic RAG1 mutation. Blood. 113:2965-2975. doi:10.1182/blood2008-07-165167
18. Herzog, K.H., M.J. Chong, M. Kapsetaki, J.I. Morgan, and P.J. McKinnon. 1998. Requirement for Atm in ionizing radiation-induced cell death in the developing central nervous system. Science. 280:1089-1091. doi:10.1126/science. 280.5366.1089
19. Huang, C.Y., G.G. Sharma, L.M. Walker, C.H. Bassing, T.K. Pandita, and B.P. Sleckman. 2007. Defects in coding joint formation in vivo in developing ATM-deficient B and T lymphocytes. J. Exp. Med. 204:1371-1381. doi:10.1084/jem.20061460
20. Kamimura, K., H. Ohi, T. Kubota, K. Okazuka, Y. Yoshikai, Y. Wakabayashi, Y. Aoyagi, Y. Mishima, and R. Kominami. 2007. Haplo-insufficiency of Bcl11b for suppression of lymphomagenesis and thymocyte development. Biochem. Biophys. Res. Commun. 355:538-542. doi:10.1016/j.bbrc.2007.02.003
21. Kastan, M.B., D.S. Lim, S.T. Kim, and D. Yang. 2001. ATM - a key determinant of multiple cellular responses to irradiation. Acta Oncol. 40:686-688. doi:10.1080/02841860152619089
22. Khor, B., and B.P. Sleckman. 2005. Intra- and inter-allelic ordering of T cell receptor beta chain gene assembly. Eur. J. Immunol. 35:964-970. doi:10.1002/eji.200425806 (Pubitemid 40425552)
23. Kohl, N.E., N. Kanda, R.R. Schreck, G. Bruns, S.A. Latt, F. Gilbert, and F.W. Alt. 1983. Transposition and amplification of oncogene-related sequences in human neuroblastomas. Cell. 35:359-367. doi:10.1016/0092-8674(83)90169-1
24. Krangel, M.S., C. Hernandez-Munain, P. Lauzurica, M. McMurry, J.L. Roberts, and X.P. Zhong. 1998. Developmental regulation of V(D)J recombination at the TCR alpha/delta locus. Immunol. Rev. 165:131-147. doi:10.1111/j.1600- 065X.1998.tb01236.x
25. Krangel, M.S., J. Carabana, I. Abbarategui, R. Schlimgen, and A. Hawwari. 2004. Enforcing order within a complex locus: current perspectives on the control of V(D)J recombination at the murine T-cell receptor alpha/delta locus. Immunol. Rev. 200:224-232. doi:10.1111/j.0105-2896.2004.00155.x
26. Lavin, M.F. 2008. Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer. Nat. Rev. Mol. Cell Biol. 9:759-769. doi:10.1038/nrm2514
27. Li, X., F. Gounari, A. Protopopov, K. Khazaie, and H. von Boehmer. 2008. Oncogenesis of T-ALL and nonmalignant consequences of overexpressing intracellular NOTCH1. J. Exp. Med. 205:2851-2861. doi:10.1084/jem.20081561
28. Lieber, M.R. 2008. The mechanism of human nonhomologous DNA end joining. J. Biol. Chem. 283:1-5. doi:10.1074/jbc.R700039200
29. Liyanage, M., Z. Weaver, C. Barlow, A. Coleman, D.G. Pankratz, S. Anderson, A. Wynshaw-Boris, and T. Ried. 2000. Abnormal rearrangement within the alpha/delta T-cell receptor locus in lymphomas from Atm-deficient mice. Blood. 96:1940-1946.
30. MacLeod, R.A., S. Nagel, and H.G. Drexler. 2004. BCL11B rearrangements probably target T-cell neoplasia rather than acute myelocytic leukemia. Cancer Genet. Cytogenet. 153:88-89. doi:10.1016/j.cancergencyto.2004.02.020
31. O'Neil, J., J. Calvo, K. McKenna, V. Krishnamoorthy, J.C. Aster, C.H. Bassing, F.W. Alt, M. Kelliher, and A.T. Look. 2006. Activating Notch1 mutations in mouse models of T-ALL. Blood. 107:781-785. doi:10.1182/blood2005062553
32. Olshen, A.B., E.S. Venkatraman, R. Lucito, and M. Wigler. 2004. Circular binary segmentation for the analysis of array-based DNA copy number data. Biostatistics. 5:557-572. doi:10.1093/biostatistics/kxh008
33. Pekarsky, Y., C. Hallas, and C.M. Croce. 2001. Molecular basis of mature T-cell leukemia. JAMA. 286:2308-2314. doi:10.1001/jama.286.18.2308 (Pubitemid 33063153)
34. Przybylski, G.K., W.A. Dik, J. Wanzeck, P. Grabarczyk, S. Majunke, J.I. Martin-Subero, R. Siebert, G. Dölken, W.D. Ludwig, B. Verhaaf, et al. 2005. Disruption of the BCL11B gene through inv(14)(q11.2q32.31) results in the expression of BCL11B-TRDC fusion transcripts and is associated with the absence of wild-type BCL11B transcripts in T-ALL. Leukemia. 19:201-208. doi:10.1038/sj.leu.2403619
35. Rooney, S., J. Chaudhuri, and F.W. Alt. 2004a. The role of the nonhomologous end-joining pathway in lymphocyte development. Immunol. Rev. 200:115-131. doi:10.1111/j.01052896.2004.00165.x
36. Rooney, S., J. Sekiguchi, S. Whitlow, M. Eckersdorff, J.P. Manis, C. Lee, D.O. Ferguson, and F.W. Alt. 2004b. Artemis and p53 cooperate to suppress oncogenic N-myc amplification in progenitor B cells. Proc. Natl. Acad. Sci. USA. 101:2410-2415. doi:10.1073/pnas.0308757101
37. Russo, G., M. Isobe, R. Gatti, J. Finan, O. Batuman, K. Huebner, P.C. Nowell, and C.M. Croce. 1989. Molecular analysis of a t(14;14) translocation in leukemic T-cells of an ataxia telangiectasia patient. Proc. Natl. Acad. Sci. USA. 86:602-606. doi:10.1073/pnas.86.2.602
38. Sleckman, B.P., C.G. Bardon, R. Ferrini, L. Davidson, and F.W. Alt. 1997. Function of the TCR alpha enhancer in alphabeta and gammadelta T cells. Immunity. 7:505-515. doi:10.1016/S10747613(00)80372-6
39. Su, X.Y., V. Della-Valle, I. Andre-Schmutz, C. Lemercier, I. Radford-Weiss, P. Ballerini, M. Lessard, M. Lafage-Pochitaloff, F. Mugneret, R. Berger, et al. 2006. HOX11L2/TLX3 is transcriptionally activated through T-cell regulatory elements downstream of BCL11B as a result of the t(5;14)(q35;q32). Blood. 108:4198-4201. doi:10.1182/blood-2006-07-032953
40. von Boehmer, H. 2004. Selection of the T-cell repertoire: receptor-controlled checkpoints in T-cell development. Adv. Immunol. 84:201-238. doi:10.1016/S0065-2776(04)84006-9
41. Wang, J.H., F.W. Alt, M. Gostissa, A. Datta, M. Murphy, M.B. Alimzhanov, K.M. Coakley, K. Rajewsky, J.P. Manis, and C.T. Yan. 2008. Oncogenic transformation in the absence of Xrcc4 targets peripheral B cells that have undergone editing and switching. J. Exp. Med. 205:3079-3090. doi:10.1084/jem.20082271
42. Wang, J.H., M. Gostissa, C.T. Yan, P. Goff, T. Hickernell, E. Hansen, S. Difilippantonio, D.R. Wesemann, A.A. Zarrin, K. Rajewsky, et al. 2009. Mechanisms promoting translocations in editing and switching peripheral B cells. Nature. 460:231-236. doi:10.1038/nature08159
43. Weng, A.P., A.A. Ferrando, W. Lee, J.P. Morris IV, L.B. Silverman, C. Sanchez-Irizarry, S.C. Blacklow, A.T. Look, and J.C. Aster. 2004. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science. 306:269-271. doi:10.1126/science.1102160
44. Xu, Y., T. Ashley, E.E. Brainerd, R.T. Bronson, M.S. Meyn, and D. Baltimore. 1996. Targeted disruption of ATM leads to growth retardation, chromosomal fragmentation during meiosis, immune defects, and thymic lymphoma. Genes Dev. 10:2411-2422. doi:10.1101/gad.10.19.2411 (Pubitemid 26341877)
45. Zhu, C., K.D. Mills, D.O. Ferguson, C. Lee, J. Manis, J. Fleming, Y. Gao, C.C. Morton, and F.W. Alt. 2002. Unrepaired DNA breaks in p53-deficient cells lead to oncogenic gene amplification subsequent to translocations. Cell. 109:811-821. doi:10.1016/S00928674(02)00770-5
46. Züñiga, M.C., P. D'Eustachio, and N.H. Ruddle. 1982. Immunoglobulin heavy chain gene rearrangement and transcription in murine T cell hybrids and T lymphomas. Proc. Natl. Acad. Sci. USA. 79:3015-3019. doi:10.1073/pnas.79.9.3015